Cargando…
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis
BACKGROUND: There are limited data describing clinical flucytosine pharmacokinetics (PK). The variability of flucytosine partitioning into the CNS is not known. We described the interindividual variability in flucytosine PK in patients with HIV-associated cryptococcal meningoencephalitis. In additio...
Autores principales: | Stott, Katharine E, Ahmadu, Ajisa, Kajanga, Cheusisime, Moyo, Melanie, Gondwe, Ebbie, Chimang’anga, Wezzie, Chasweka, Madalitso, Unsworth, Jennifer, Jimenez-Valverde, Ana, Jagota, Bhavana, Shah, Reya V, Lawrence, David S, Lalloo, David G, Harrison, Tom, Jarvis, Joseph N, Hope, William, Mwandumba, Henry C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068416/ https://www.ncbi.nlm.nih.gov/pubmed/36857467 http://dx.doi.org/10.1093/jac/dkad038 |
Ejemplares similares
-
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
por: Stott, Katharine E, et al.
Publicado: (2022) -
Flucytosine and its clinical usage
por: Sigera, L. Shamithra M., et al.
Publicado: (2023) -
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022) -
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020) -
Gelatinous pseudocysts in cryptococcal meningoencephalitis
por: Ribeiro, Bruno Niemeyer de Freitas, et al.
Publicado: (2020)